A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/10/2002	US20020146708 Diagnosing cancer in humans; obtain sample, detect expression of chymotrypsin, presence of chymotrypsin enzyme indicates cancer
10/10/2002	US20020146684 Generating preferential compounds; obtain protection compounds, incubate with chemical intermediates, remove terminal buliding blocks, recover compound
10/10/2002	US20020146683 Modified hiv env polypeptides
10/10/2002	US20020146471 For maintenance of a state of wellness in which sexual health is improved
10/10/2002	US20020146448 B-glucans encapsulated in liposomes
10/10/2002	US20020146436 For protection of bovines and canines from abortion caused by Neospora caninum
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	US20020146434 As vaccine or gene vaccine; diagnostic reagent capable of accurately detecting infections with an epidemic strain of measles virus
10/10/2002	US20020146433 Vaccines
10/10/2002	US20020146432 Porcine circoviruses, vaccines and diagnostic reagents
10/10/2002	US20020146431 For prophylaxis of porcine multisystemic wasting syndrome (PMWS)
10/10/2002	US20020146430 Use of ClyA hemolysin for excretion of proteins
10/10/2002	US20020146429 Live vaccines for allergy treatment
10/10/2002	US20020146427 DNA encoding bovine immunoglobulin a inducing protein and uses therefor
10/10/2002	US20020146426 Administering molecule joined to a heat shock protein or molecule joined to an adenosinetriphosphate (ATP) binding domain of a heat shock protein inducing an immune response that includes a CD8+ cytotoxic T lymphocyte (CTL) response
10/10/2002	US20020146425 For therapy and prophylaxis of chlamydia diseases in cats
10/10/2002	US20020146423 Protective helicobacter antigens
10/10/2002	US20020146422 For therapy of asthma; allergies to pollen, fur, and/or house dust; various food allergies; and various forms of eczema
10/10/2002	US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002	US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002	US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002	US20020146415 Methods for inhibiting HIV-1 infection
10/10/2002	US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002	US20020146410 Monoclonal antibodies and their use
10/10/2002	US20020146408 Human haemopoietic maturation factor
10/10/2002	US20020146397 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
10/10/2002	US20020146396 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
10/10/2002	US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002	DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002	DE10116594A1 Künstliche Chromosomen, die EHV-Sequenzen umfassen Include artificial chromosomes EHV sequences
10/10/2002	DE10115073A1 Verwendung von Inhibitoren von IKK-ß und Verfahren zum Auffinden solcher Inhibitoren Use of inhibitors of IKK-ß and methods for finding such inhibitors
10/10/2002	DE10112851C1 Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen Semi-allogeneic anti-tumor vaccine with HLA haplo-identical antigen presenting cells
10/10/2002	CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002	CA2446804A1 Secreted streptococcus pneumoniae proteins
10/10/2002	CA2443138A1 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002	CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002	CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002	CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002	CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002	CA2442619A1 Cancer-testis antigens
10/10/2002	CA2442532A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002	CA2442531A1 Peptides and antibodies to muc 1 proteins
10/10/2002	CA2442346A1 Nucleic acids encoding isav polypeptides
10/10/2002	CA2442298A1 Leishmania vaccines
10/10/2002	CA2442149A1 Viral vectors
10/10/2002	CA2442123A1 Adp-ribosylating bacterial toxins
10/10/2002	CA2442062A1 Secreted proteins
10/10/2002	CA2442020A1 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002	CA2441863A1 Drugs containing genetically modified antibody against ganglioside gd3
10/10/2002	CA2441654A1 Cytoskeleton-associated proteins
10/10/2002	CA2440874A1 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
10/10/2002	CA2440831A1 Combination therapy using cd40 and cd20 ligands
10/10/2002	CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002	CA2437099A1 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002	CA2437095A1 Methods and compositions for modulating the immune system of animals
10/10/2002	CA2435828A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002	CA2429265A1 Mammalian alpha-helical protein-53
10/09/2002	EP1247865A2 Antibody for use in therapy
10/09/2002	EP1247817A2 Human CD23-like protein and nucleic acids encoding it
10/09/2002	EP1247816A1 Immunogen, antivenom and vaccine against the venom of the black widow spider
10/09/2002	EP1247100A1 Interaction between cd14 and hbv components
10/09/2002	EP1247099A2 Methods and compositions for detecting hepatitis e virus
10/09/2002	EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002	EP1246929A2 Methods and compositions for obtaining disease protection for animals
10/09/2002	EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002	EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002	EP1246917A2 Human stra6 polypeptides
10/09/2002	EP1246901A1 Methods for protein transfer
10/09/2002	EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246843A1 Novel fgf homolog zfgf12
10/09/2002	EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002	EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002	EP1246647A1 Non-immunosuppressant hiv tat
10/09/2002	EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/09/2002	EP1246645A2 A stable immunogenic composition for frozen storage
10/09/2002	EP1246644A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
10/09/2002	EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40
10/09/2002	EP1246634A1 Methods for treating pancreatic disorders
10/09/2002	EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
10/09/2002	EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002	EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0900087B1 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
10/09/2002	EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002	EP0868434B1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/09/2002	EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002	EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002	EP0640098B1 Canine coronavirus s gene and uses therefor
10/09/2002	CN1373807A Mosaic infections bursal disease virus vaccines
10/09/2002	CN1373805A Antigenic meningococcal peptides
10/09/2002	CN1373771A Vaccine
10/09/2002	CN1373672A Blocking immune response to foreign antigen using antagonist which binds to CD20
10/09/2002	CN1373671A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/09/2002	CN1373224A Construction of efficient expression plasmid for hog cholera virus (CSFV) E2 antigen procaryon and process for preparing CSFVE2 antigen in large scale
10/09/2002	CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/09/2002	CN1092045C Vesicular complexes and methods of making and using same
10/08/2002	US6462079 Pharmaceutical composition and method of using the same
10/08/2002	US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity

1 ... 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 ... 1823